Search Results - "Zoltick, Emilie S"

Refine Results
  1. 1

    Sugar-sweetened beverage, artificially sweetened beverage and sugar intake and colorectal cancer survival by Zoltick, Emilie S., Smith-Warner, Stephanie A., Yuan, Chen, Wang, Molin, Fuchs, Charles S., Meyerhardt, Jeffrey A., Chan, Andrew T., Ng, Kimmie, Ogino, Shuji, Stampfer, Meir J., Giovannucci, Edward L., Wu, Kana

    Published in British journal of cancer (28-09-2021)
    “…Background The influence of a high sugar diet on colorectal cancer (CRC) survival is unclear. Methods Among 1463 stage I–III CRC patients from the Nurses’…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Racial and ethnic representation of youth in type 1 diabetes interventional trials by Zoltick, Emilie S., Wu, Ann Chen, Ong, Mei-Sing

    Published in Contemporary clinical trials (01-11-2024)
    “…Underrepresentation of racial and ethnic groups in clinical trials can limit generalizability of research findings and equitable access to treatment. This…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Attitudes about pharmacogenomic testing vary by healthcare specialty by Preys, Charlene L, Blout Zawatsky, Carrie L, Massmann, Amanda, Heukelom, Joel Van, Green, Robert C, Hajek, Catherine, Hickingbotham, Madison R, Zoltick, Emilie S, Schultz, April, Christensen, Kurt D

    Published in Pharmacogenomics (01-07-2023)
    “…To understand how attitudes toward pharmacogenomic (PGx) testing among healthcare providers varies by specialty. Providers reported comfort ordering PGx…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Primary Care Providers' Experiences With an Active Elective Genetic Testing Program by Platt, Dylan M, Blout Zawatsky, Carrie L, Christensen, Kurt D, Green, Robert C, Hajek, Catherine, Hickingbotham, Madison R, Hutchinson, Allison M, LeBlanc, Jessica L, Zoltick, Emilie S, Jamal, Leila

    Published in Health education & behavior (30-07-2024)
    “…Elective genetic testing (EGT) programs that provide pharmacogenomic information to guide medication management and screen for medically actionable disease…”
    Get full text
    Journal Article
  14. 14

    SLCO1B1 gene-based clinical decision support reduces statin-associated muscle symptoms risk with simvastatin by Massmann, Amanda, Van Heukelom, Joel, Green, Robert C, Hajek, Catherine, Hickingbotham, Madison R, Larson, Eric A, Lu, Christine Y, Wu, Ann Chen, Zoltick, Emilie S, Christensen, Kurt D, Schultz, April

    Published in Pharmacogenomics (01-05-2023)
    “…variants are known to be a strong predictor of statin-associated muscle symptoms (SAMS) risk with simvastatin. The authors conducted a retrospective chart…”
    Get full text
    Journal Article
  15. 15

    Familial communication and cascade testing following elective genomic testing by Adelson, Sophia M, Blout Zawatsky, Carrie L, Hickingbotham, Madison R, Bell, Megan E, Platt, Dylan M, Leonhard, Jennifer R, Zoltick, Emilie S, Hajek, Catherine A, Green, Robert C, Christensen, Kurt D

    Published in Journal of genetic counseling (16-05-2024)
    “…Familial communication of results and cascade genetic testing (CGT) can extend the benefits of genetic screening beyond the patient to their at-risk relatives…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Patient and Societal Value Functions for the Testing Morbidities Index by Swan, J. Shannon, Kong, Chung Yin, Lee, Janie M., Itauma, Omosalewa, Halpern, Elkan F., Lee, Pablo A., Vavinskiy, Sergey, Williams, Olubunmi, Zoltick, Emilie S., Donelan, Karen

    Published in Medical decision making (01-08-2013)
    “…Background: We developed preference-based and summated scale scoring for the Testing Morbidities Index (TMI) classification, which addresses short-term effects…”
    Get full text
    Journal Article
  20. 20